Drug intelligence / Profile preview

epinephrine + nitroglycerin + aspirin + albuterol sulfate + anhydrous dextrose + diphenhydramine

Development stage
Unknown
Modality
Small Molecules
Administration
Intramuscular, Inhalation, Oral, Sublingual
01

Overview

This product is a **multi-drug emergency kit** containing epinephrine, nitroglycerin, aspirin, albuterol sulfate, anhydrous dextrose, and diphenhydramine, consistent with a dental office emergency kit rather than a single molecular entity. The clinically most important therapeutic component for the provided indication context is **epinephrine**, a non-selective alpha- and beta-adrenergic receptor agonist used for the emergency treatment of severe allergic reactions including anaphylaxis, exercise-induced anaphylaxis, and idiopathic anaphylaxis. The additional components support management of other acute office emergencies: **albuterol sulfate** as an inhaled beta-2 adrenergic receptor agonist bronchodilator, **diphenhydramine** as an H1 antihistamine, **nitroglycerin** as a nitric oxide-donating vasodilator for angina, **aspirin** as an irreversible cyclooxygenase inhibitor with antiplatelet effects, and **anhydrous dextrose** as a rapidly absorbable carbohydrate source for hypoglycemia support. The exact marketed kit identity and manufacturer for this exact ingredient string could not be confirmed with high specificity from the provided context, so the annotation treats it as a verified multi-ingredient pharmaceutical kit concept rather than a uniquely branded asset.

Other names
epinephrine + nitroglycerin + aspirin + albuterol sulfate + anhydrous dextrose + diphenhydramine
02

Targets

HRH1 (Histamine H1 Receptor)ADRA2A (α2A)ADRA1A (α1A)ADRB2 (β2)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)sGC (Soluble Guanylyl Cyclase)PGHS-1 (Prostaglandin G/H Synthase 1)ADRB1 (β1)

Beyond the preview

Go deeper on epinephrine + nitroglycerin + aspirin + albuterol sulfate + anhydrous dextrose + diphenhydramine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on epinephrine + nitroglycerin + aspirin + albuterol sulfate + anhydrous dextrose + diphenhydramine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call